Multi-Purpose Primer Part A

SECTION 2: Hazards identification

NFPA and HMIS RATINGS: NFPA Hazard HMIS Hazard Rating Health 1 Health 1 Flammable 0 Flammable 0 Reactive 0 Reactive 0 Special Hazards - Personal Protection X

Signal word

Warning GHS

2.1 Classification of the substance or mixture

Skin irritation (Category 2) Skin sensitization (Category 1)

Hazard statements

Causes skin irritation May cause an allergic skin reaction. Contains materials suspected of causing cancer (bound in liquid/paint, not airborne dust).

Precautionary statements

Wash hands thoroughly after handling. Wear protective gloves/ eye protection/face protection. Avoid breathing dust/fume/gas/mist/vapors/spray. Contaminated work clothing must not be allowed out of the workplace. If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. If on skin: Wash with plenty of water. Take off contaminated clothing and wash it before reuse. If skin irritation or rash occurs: Get medical advice/attention. Dispose of contents and container in accordance with all local, regional, national and international regulations. ADDITIONAL HAZARD IDENTIFICATION INFORMATION:

Principle Routes of Exposure

Inhalation, Skin Absorption, Ingestion, Eye SIGNS & SYMPTOMS OF EXPOSURE EYES: May cause eye irritation. Symptoms may include discomfort or pain, excess blinking and tear production, with possible redness and swelling. SKIN: Causes skin irritation. Symptoms may include redness, edema, drying, defatting and cracking of the skin. May cause sensitization by skin contact. INGESTION: May be harmful if swallowed. May cause stomach distress, nausea or vomiting. INHALATION: May cause respiratory tract irritation.

Acute Health Hazards

See above.

Health hazards

See below. CARCINOGENICITY: IARC has determined that occupational exposure to Titanium Dioxide is possibly carcinogenic to humans (Group 2B). IARC concluded lung tumors were observed in rats following high dose exposure by inhalation and in female rats exposed by intra-tracheal instillation. Other studies have shown no tumors in rats following inhalation exposure and no tumors in mice or rats following oral exposure. Occupational exposure to respirable crystalline silica is classified as a known carcinogen in humans. IARC has determined that respirable crystalline silica is carcinogenic to human (Group 1), based on findings of sufficient evidence of carcinogenicity in both humans and experimental animals. NTP has classified respirable crystalline silica as a known human carcinogen based on sufficient evidence of carcinogenicity from studies in humans indicating a causal relationship between exposure to respirable crystalline silica and increased lung cancer rates in workers exposed to crystalline silica dust. NIOSH has determined that respirable crystalline silica is a potential occupational carcinogen.